CFTR and cystic fibrosis: Modulator therapies represent a fundamental change in CF’s treatment, meaning a transition from addressing complications of a disease resulting from CFTR proteins’ defect, to the restoration of partial function of this defective protein, consequently determining disease modification [116,117].